HomeHealthUK Trial Shows Two-Stage Prostate Cancer MRI Scans Match Three-Stage in Accuracy,...

UK Trial Shows Two-Stage Prostate Cancer MRI Scans Match Three-Stage in Accuracy, Halve Costs

Published on

A groundbreaking UK trial has established that two-stage MRI scans for prostate cancer are as effective as the traditional three-stage scans, promising reduced costs and increased accessibility for patients. The trial, conducted by researchers from University College London (UCL) and University College London Hospitals, has significant implications for the detection and management of prostate cancer, which affects an estimated 52,300 men each year in the UK alone according to Cancer Research UK.

The conventional three-stage MRI protocol includes a contrast dye injection in the third phase to enhance image clarity. However, the Prime trial, encompassing 555 patients across 22 hospitals in 12 countries, demonstrated that the elimination of this contrast stage does not compromise the scan’s ability to accurately identify significant prostate cancers. The researchers found that the diagnosis rates remained at 29% for both the two-stage and three-stage processes.

Dr. Clare Allen, the lead radiologist on the trial, emphasized the potential benefits: “The scans will be quicker, cheaper and can be offered to more men,” highlighting that the cost of a three-phase MRI averages £273, while the two-phase scan could be almost 50% cheaper at £145.

The Prime trial’s findings were presented at the European Association of Urology conference in Paris, drawing attention from the medical community. Dr. Francesco Giganti, a radiologist involved in the study, said that “Being able to make accurate diagnoses without the contrast stage will reduce scan time by around a third, meaning we can offer scans to more men using the same number of scanners and operators.”

Matthew Hobbs, director of research at Prostate Cancer UK, which co-funded the trial, said the results mean men can now be given quicker scans that do not require an injection and are cheaper. “This will allow more men to benefit from a better, more accurate diagnosis at a lower cost to healthcare systems not only in the UK, but worldwide.”

These trial results come amid discussions on the effectiveness of prostate cancer screening methods. Another study, the Cap trial, indicated that PSA blood tests used for screening do not significantly reduce prostate cancer deaths and could result in both overdiagnosis and missed aggressive cancers.

In stark contrast, the Prime trial suggests that MRI scans could offer a safer, more accurate alternative, with the two-stage method further streamlining the process.

Relevant articles:
– Cheaper, quicker prostate cancer scans just as accurate ‘and can help more men’
– Cutting length of prostate cancer MRI could save lives, new research reveals, inews, Sat, 06 Apr 2024 08:55:00 GMT

LEAVE A REPLY

Latest articles

Evolution of Precision: The Unmatched Role of Modern Sniper Rifles in Military and Law Enforcement

The role of sniper rifles has evolved remarkably over the last two decades, with...

More like this

Justice Alito Stands Firm, Refusing Recusal from Trump-Related Supreme Court Cases

Supreme Court Justice Samuel Alito is resolute in his decision to not recuse himself...

U.S. and Saudi Arabia Nearing Defense Pact: Strategic Shift or Political Gamble?

The Biden administration is apparently close to finalizing a defense pact with Saudi Arabia,...

Ukraine’s Strategic Strikes in Crimea: Unpacking the Use of Storm Shadow Missiles

The recent reports of Ukraine's utilization of Storm Shadow missiles in the Crimean territory...